Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VidPrevtyn Beta vs Comirnaty Bivalent Booster in Adults
NCT05749926Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2023
- Primary completion
- Jul 2023
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of monovalent [B.1.351] CoV2 preS dTM-AS03 in coronavirus disease 2019 (COVID-19), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
monovalent [B.1.351] CoV2 preS dTM-AS03
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05749926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05749926.